Markets:

Overview

News

Currencies

International

Treasuries

Channel Therapeutics Corporation Common Stock (NY:CHRO)

1.350 UNCHANGED

Last Price Updated: 8:00 PM EDT, Jul 1, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Channel Therapeutics Corporation Common Stock

< Previous 1 2 Next >

Pelthos Therapeutics Launches First At-Home Prescription Gel For Highly Contagious Skin Disease ↗

July 10, 2025

Pelthos launches Zelsuvmi, the first FDA-approved at-home prescription gel for molluscum, shown to clear lesions in as little as two weeks.

Via Benzinga

Get insights into the top gainers and losers of Tuesday's pre-market session. ↗

July 01, 2025

Wondering what's happening in Tuesday's pre-market session? Find an overview in this article.

Via Chartmill

Why Is Channel Therapeutics Stock Surging On Friday? ↗

June 27, 2025

Channel Therapeutics shares rise after announcing 10-for-1 reverse stock split and upcoming rebrand.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 14, 2025

Via Benzinga

EXCLUSIVE: Channel Therapeutics Touts Positive Efficacy Results For Eye Treatment Potential In Multiple Preclinical In Vivo Models ↗

May 14, 2025

Channel Therapeutics reports CT2000 reduced eye pain in preclinical trials, with plans to enter human testing for acute and chronic indications.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 21, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 17, 2025

Via Benzinga

Power Metallic (OTCQB: PNPNF | TSX.V: PNPN): An Undervalued Critical Metals Stock Alongside HTZ, SMX, TGL, CHRO – Trading Under $5

April 17, 2025

Via AB Newswire

Gold Falls Over 1%; D.R. Horton Posts Downbeat Earnings ↗

April 17, 2025

Via Benzinga

Channel Therapeutics Stock Soars On Announcement Of Subsidiary’s Merger With Ligand Pharma Units: Retail’s Elated ↗

April 17, 2025

Under the agreement, Ligand’s wholly owned subsidiaries, Pelthos Therapeutics Inc. and LNHC, Inc. will combine with CHRO Merger Sub Inc., a wholly-owned subsidiary of Channel.

Via Stocktwits

Dow Falls Over 1%; US Initial Jobless Claims Decline ↗

April 17, 2025

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 17, 2025

Via Benzinga

EXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused Entity ↗

April 17, 2025

Ligand and Channel Therapeutics to merge in $50 million deal to launch Zelsuvmi for molluscum and advance NaV 1.7 chronic pain programs.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 23, 2025

Via Benzinga

Why Poseida Therapeutics Shares Are Trading Higher By 219%; Here Are 20 Stocks Moving Premarket ↗

November 26, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 18, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 18, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 16, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

October 04, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 04, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 01, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 26, 2024

Via Benzinga

Life Sciences Virtual Investor Forum Agenda Announced for September 19th

September 16, 2024

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

CHRO Stock Earnings: Chromocell Therapeutics Reported Results for Q2 2024 ↗

August 20, 2024

Chromocell Therapeutics just reported results for the second quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 29, 2024

Via Benzinga

CHRO Stock Earnings: Chromocell Therapeutics Reported Results for Q1 2024 ↗

May 20, 2024

Chromocell Therapeutics just reported results for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 13, 2024

Via Benzinga

Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 19, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 19, 2024

Via Benzinga

Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 17, 2024

Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.